Marpai, Inc. (MRAI)
| Market Cap | 21.89M |
| Revenue (ttm) | 37.16M |
| Net Income (ttm) | -28.75M |
| Shares Out | 10.30M |
| EPS (ttm) | -4.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,372 |
| Open | 2.140 |
| Previous Close | 2.090 |
| Day's Range | 2.100 - 2.220 |
| 52-Week Range | 0.330 - 3.472 |
| Beta | 5.39 |
| Analysts | Strong Buy |
| Price Target | 6.00 (+182.35%) |
| Earnings Date | May 8, 2024 |
About MRAI
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services. It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York. [Read more]
Financial Performance
In 2023, Marpai's revenue was $37.16 million, an increase of 52.64% compared to the previous year's $24.34 million. Losses were -$28.75 million, 8.63% more than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for MRAI stock is "Strong Buy" and the 12-month stock price forecast is $6.0.
News
MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES
Financing Strengthens Marpai's Growth Trajectory TAMPA, Fla. , April 16, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administratio...
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Full Year Benefit of Maestro Acquisition and Q4 Corrective Actions Driving Financial Improvement TAMPA, Fla. , March 26, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a...
NASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTS
TAMPA, Fla., March 13, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA m...
MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
Full Year Impact of Maestro Acquisition and Q4 Corrective Actions Driving Improvement TAMPA, Fla. , March 6, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independen...
MARPAI ANNOUNCES "OFF-CYCLE" NEW CLIENT AGREEMENT
Marpai executes new client agreement furthering its expansion in the Southeast. TAMPA, Fla.
MARPAI ANNOUNCES KEY FINANCIAL AGREEMENTS
Marpai executes amendment with AXA delaying payment obligations and secures $1.7 million in revenue-based financing from Libertas Funding, LLC. NEW YORK , Feb. 8, 2024 /PRNewswire/ -- Marpai, Inc. (...
MARPAI HIRES JOHN POWERS AS PRESIDENT
Accomplished Industry Veteran with Proven Track Record of Successful High Growth Operations to support Marpai's vision of Affordable, Intelligent, Healthcare NEW YORK , Jan. 12, 2024 /PRNewswire/ -- M...
MARPAI, INC. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS
NEW YORK , Dec. 13, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA marke...
MARPAI, INC. REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE COMPLIANCE
NEW YORK , Dec. 6, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA market...
MARPAI, INC. CONFIRMS IT HAS FILED AN APPEAL TO NASDAQ DELISTING LETTER
Delisting or suspension action stayed pending the issuance of a final decision NEW YORK , Dec. 1, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national ...
MARPAI TO HOST INVESTOR WEBCAST ON NOVEMBER 29, 2023
NEW YORK , Nov. 23, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administrator (TPA) company transforming the $22 billion TPA marke...
MARPAI, INC. REPORTS THIRD QUARTER 2023 RESULTS
Continued year over year growth related to our acquisition of Maestro Health Further identification and implementation of synergies and opportunities continue as a result of the acquisition Veteran in...
Marpai Names Damien Lamendola as Chief Executive Officer to Drive the Next Phase of its Growth
Healthcare Industry Luminary is also the Company's Largest Shareholder NEW YORK , Nov. 6, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a full-service Third-Party Admin...
Top 5 Financial Stocks You'll Regret Missing This Quarter
The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
MARPAI, INC. REPORTS SECOND QUARTER 2023 RESULTS
NEW YORK , Aug. 3, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a technology company transforming the $22 billion Third-Party Administrator (TPA) market supporting sel...
MARPAI TO HOST CALL ON AUGUST 3, 2023 TO DISCUSS SECOND QUARTER 2023 FINANCIAL RESULTS
NEW YORK , July 27, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded he...
MARPAI LAUNCHES NEW HEALTH PLAN FOR SMALL EMPLOYERS
PLAN ENABLES EASY TRANSITION TO SELF-FUNDING FOR SMALLER EMPLOYERS NEW YORK , July 18, 2023 /PRNewswire/ -- Marpai, Inc . ("Marpai" or the "Company") (Nasdaq: MRAI), a smart technology Third-Party Ad...
MARPAI COLLABORATES WITH NUVOAIR TO OFFER VALUE-BASED CARDIOPULMONARY CARE TO SELF-FUNDED EMPLOYER HEALTH PLANS
Marpai adds industry-leading virtual specialty care provider to its value-based care network to improve member health and lower employer costs. NEW YORK , July 5, 2023 /PRNewswire/ -- Marpai, Inc. ("M...
Marpai Confirms Revenue Guidance for Q2 2023 of $9.5 Million to $9.8 Million
Company cites expected improvements in EBITDA NEW YORK , June 29, 2023 /PRNewswire/ -- Marpai, Inc . ("Marpai" or the "Company") (Nasdaq: MRAI), an AI-powered Third-Party Administrator (TPA) transform...
Marpai Announces Reverse Stock Split
NEW YORK , June 28, 2023 /PRNewswire/ -- Marpai, Inc . ("Marpai" or the "Company") (Nasdaq: MRAI), an artificial intelligence (AI) enabled Third-Party Administrator (TPA) transforming self-funded empl...
Marpai Announces Agreement with Oshi Health to Offer High-Quality Virtual Digestive Health Care to Self-Funded Employer Health Plans
Marpai adds industry-leading virtual multidisciplinary gastrointestinal care clinic to its value-based care network to improve member health and lower employer costs. NEW YORK , June 8, 2023 /PRNewswi...
Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare
Marpai Connect proactively matches members to best-in-class value-based providers to improve member health and lower costs for employers NEW YORK , May 30, 2023 /PRNewswire/ -- Marpai, Inc . ("Marpai"...
MARPAI, INC. REPORTS FIRST QUARTER 2023 RESULTS
NEW YORK , May 10, 2023 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), a technology company transforming the $22 billion Third-Party Administrator (TPA) market supporting sel...
Marpai to Host Call on May 11, 2023 to Discuss First Quarter 2023 Financial Results
NEW YORK--(BUSINESS WIRE)--Marpai, Inc. ("Marpai" or the “Company”) (Nasdaq: MRAI), a deep learning technology company transforming third-party administration (TPA) in the self-funded health insurance...
Marpai, Inc. Announces Closing of Public Offering
NEW YORK--(BUSINESS WIRE)--Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), a technology company using artificial intelligence (A.I.) to transform health plans for employers that self-fund the...